Summary of Key Points
After Luoyang Xiangshun Guarantee Company collapsed due to illegal public deposit fundraising, the government facilitated the conversion of more than 4,000 investors' claims into equity in the unfinished Jingdu Tumor Hospital. However, the hospital has been in preparation for 12 years without opening. During this time, it has undergone multiple changes in ownership, faced equity disputes, and encountered difficulties with cross-regional coordination (the case is under the jurisdiction of Jianxi District while the hospital is located in the old city area). Additionally, concerns about radiation from the proton therapy project have raised residents' fears, resulting in the continuous disappointment of investors who hope to recover their money.
Detailed Analysis
1. Conversion of Debt into Equity: A Reluctant Gamble from “Victims” to “Shareholders”
In the Xiangshun Guarantee case, investors were considered criminal victims and should have been able to recover part of their principal through asset recovery. However, the government promoted a “debt-to-equity” scheme, converting the investors' claims into shares in the Jingdu Hospital, with the hope that they would benefit from future dividends.
- Details of the Agreement: The investors signed a “Convertible Debt Agreement” that stipulated the equity ratio to be calculated based on the investment amount divided by the total hospital investment (1.1 billion yuan for the first phase). Xiangshun Guarantee transferred the debt to an affiliated company and issued debt receipts to the investors.
- Hidden Risks: The hospital was not yet completed, and it was uncertain whether it would open or be profitable. Investors essentially bet their hard-earned money on a project with no solid foundation; if the hospital failed, their investment would be lost.
2. The Hospital’s Failure to Open After 10 Years of Preparation
Jingdu Hospital began preparations in 2010 and was originally scheduled to open in 2015, but there has been no progress:
- Changes in Ownership: In 2018, the original owner, Peng Minsheng (who was later convicted), withdrew from the project, and the hospital became a subsidiary of Fulan Real Estate. Later, Fulan pledged its equity to Guangdong Boai Medical Group, but disputes between them led to the project’s stagnation.
- Proton Therapy Project: In 2024, a state-owned proton therapy project started construction at the same site, claiming to be an expansion of Jingdu Hospital with a total investment of 2 billion yuan. However, residents complained about radiation risks, and the Health Commission did not approve the project, with the construction party also facing procedural issues.
- Huge Debt Burden: Staff from the new investor acknowledged that the project’s debt was too substantial, making it difficult to attract funding and slowing progress.
3. Cross-Regional Coordination Issues
The Xiangshun Guarantee case is under the jurisdiction of Jianxi District, but the hospital is in the old city area, leading to mutual shirking of responsibilities:
- Jianxi District: Asset clearance requires cooperation from the old city area, which has not responded.
- Old City Area: They are willing to assist with site clearance only if Jianxi determines the investor.
- Hidden Problems: The hospital’s land was previously mortgaged to a Beijing-based company, complicating asset disposal and further delaying the project.
4. Investors’ Dilemma
After 12 years of waiting, investors have faced:
- Frequent Changes in Owners: From Peng Minsheng to Fulan, and then to the state-owned proton therapy project, each new owner promised investment but made no progress.
- Contradictory Government Statements: Jianxi District claims a new investor has been found and will buy the shares, while the old city area points out incomplete construction procedures; the investors’ funds are still at risk.
- Dying Hope: Despite occasional positive signals within the investor community, the stalled project, the government’s inaction, and the indefinitely postponed opening have left them increasingly disheartened, believing they may never get their money back.
5. The Proton Therapy Project: A New Hope or Another Problem?
The state-owned proton therapy project was seen as a potential saving grace for investors, but it comes with many issues:
- Resident Opposition: Nearby residents oppose the project due to concerns about radiation from the equipment.
- Procedural Issues: The Health Commission has not approved the project, indicating that the hospital lacks basic operational qualifications.
- Funding Doubts: The new investor’s heavy debt burden makes it uncertain whether the 2 billion yuan in investment will be secured. Even if completed, there is no guarantee of profitability or dividends for shareholders.
Conclusion
In essence, the “debt-to-equity” scheme shifted investors’ risks from the guarantee company to the unfinished hospital. Poor cross-regional coordination, multiple changes in ownership, and resident opposition have pushed the opening of the hospital far into the future. Investors, who were initially victims of illegal fundraising, have now become shareholders in a lengthy wait with no clear outcome for their investments.